{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:51:10Z","timestamp":1785523870818,"version":"3.56.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-70709-4","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:22:44Z","timestamp":1785226964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Racial and ethnic disparities in the cause of death for clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"17","author":[{"given":"Yingwei","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-8461","authenticated-orcid":false,"given":"Zaosong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2912-0965","authenticated-orcid":false,"given":"Hao","family":"Ping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,28]]},"reference":[{"key":"70709_CR1","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1590\/0100-3984.2013.1927","volume":"48","author":"VF Muglia","year":"2015","unstructured":"Muglia, V. F. & Prando, A. Renal cell carcinoma: histological classification and correlation with imaging findings. Radiol. Bras. 48, 166\u2013174 (2015).","journal-title":"Radiol. Bras."},{"key":"70709_CR2","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"70709_CR3","doi-asserted-by":"publisher","first-page":"e249449","DOI":"10.1001\/jamanetworkopen.2024.9449","volume":"7","author":"JQ Freeman","year":"2024","unstructured":"Freeman, J. Q. et al. Declination of treatment, racial and ethnic disparity, and overall survival in US patients with breast cancer. JAMA Netw. Open 7, e249449 (2024).","journal-title":"JAMA Netw. Open"},{"key":"70709_CR4","doi-asserted-by":"publisher","first-page":"e240044","DOI":"10.1001\/jamanetworkopen.2024.0044","volume":"7","author":"RM Shulman","year":"2024","unstructured":"Shulman, R. M. et al. Factors associated with racial and ethnic disparities in locally advanced rectal cancer outcomes. JAMA Netw. Open 7, e240044 (2024).","journal-title":"JAMA Netw. Open"},{"key":"70709_CR5","doi-asserted-by":"publisher","first-page":"e2345906","DOI":"10.1001\/jamanetworkopen.2023.45906","volume":"6","author":"TM Ma","year":"2023","unstructured":"Ma, T. M. et al. Racial and ethnic disparities in use of novel hormonal therapy agents in patients with prostate cancer. JAMA Netw. Open 6, e2345906 (2023).","journal-title":"JAMA Netw. Open"},{"key":"70709_CR6","doi-asserted-by":"publisher","first-page":"e2344517","DOI":"10.1001\/jamanetworkopen.2023.44517","volume":"6","author":"AM Roy","year":"2023","unstructured":"Roy, A. M. et al. Racial and ethnic disparity in preoperative chemosensitivity and survival in patients with early-stage breast cancer. JAMA Netw. Open 6, e2344517 (2023).","journal-title":"JAMA Netw. Open"},{"key":"70709_CR7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1007\/s40615-022-01257-y","volume":"10","author":"C Wurnschimmel","year":"2023","unstructured":"Wurnschimmel, C. et al. Race\/ethnicity may be an important predictor of life expectancy in localized prostate cancer patients: novel analyses using social security administration life tables. J. Racial Ethn. Health Disparities 10, 708\u2013717 (2023).","journal-title":"J. Racial Ethn. Health Disparities"},{"key":"70709_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102138","volume":"62","author":"H Zeng","year":"2023","unstructured":"Zeng, H. et al. Racial\/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study. EClinicalMedicine 62, 102138 (2023).","journal-title":"EClinicalMedicine"},{"key":"70709_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/cncr.27690","volume":"119","author":"WH Chow","year":"2013","unstructured":"Chow, W. H., Shuch, B., Linehan, W. M. & Devesa, S. S. Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer 119, 388\u2013394 (2013).","journal-title":"Cancer"},{"key":"70709_CR10","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.urology.2003.07.010","volume":"62","author":"UN Vaishampayan","year":"2003","unstructured":"Vaishampayan, U. N., Do, H., Hussain, M. & Schwartz, K. Racial disparity in incidence patterns and outcome of kidney cancer. Urology 62, 1012\u20131017 (2003).","journal-title":"Urology"},{"key":"70709_CR11","doi-asserted-by":"publisher","first-page":"460.e461","DOI":"10.1016\/j.urolonc.2023.08.016","volume":"41","author":"R Alam","year":"2023","unstructured":"Alam, R. et al. Socioeconomic determinants of racial disparities in survival outcomes among patients with renal cell carcinoma. Urol. Oncol. 41, 460.e461\u2013460.e469 (2023).","journal-title":"Urol. Oncol."},{"key":"70709_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.urology.2020.10.055","volume":"148","author":"D Jivanji","year":"2021","unstructured":"Jivanji, D. et al. The association between race and 5-year survival in patients with clear cell renal cell carcinoma: a cohort study. Urology 148, 185\u2013191 (2021).","journal-title":"Urology"},{"key":"70709_CR13","doi-asserted-by":"publisher","first-page":"7869","DOI":"10.2147\/IJGM.S340284","volume":"14","author":"X Li","year":"2021","unstructured":"Li, X., Xu, Z., Xu, T., Qi, F. & Song, N. Basic characteristics and survival outcomes of Asian-American patients with clear cell renal cell carcinoma and comparisons with White patients: a population-based analysis. Int. J. Gen. Med. 14, 7869\u20137883 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"70709_CR14","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.juro.2008.01.027","volume":"179","author":"HS Stafford","year":"2008","unstructured":"Stafford, H. S. et al. Racial\/ethnic and gender disparities in renal cell carcinoma incidence and survival. J. Urol. 179, 1704\u20131708 (2008).","journal-title":"J. Urol."},{"key":"70709_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/JCO.2009.22.4816","volume":"28","author":"A Kutikov","year":"2010","unstructured":"Kutikov, A., Egleston, B. L., Wong, Y. N. & Uzzo, R. G. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram. J. Clin. Oncol. 28, 311\u2013317 (2010).","journal-title":"J. Clin. Oncol."},{"key":"70709_CR16","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1200\/JCO.2006.10.0156","volume":"25","author":"SI Berndt","year":"2007","unstructured":"Berndt, S. I., Carter, H. B., Schoenberg, M. P. & Newschaffer, C. J. Disparities in treatment and outcome for renal cell cancer among older Black and White patients. J. Clin. Oncol. 25, 3589\u20133595 (2007).","journal-title":"J. Clin. Oncol."},{"key":"70709_CR17","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.juro.2008.10.159","volume":"181","author":"NJ Hellenthal","year":"2009","unstructured":"Hellenthal, N. J., Chamie, K., Ramirez, M. L. & deVere White, R. W. Sociodemographic factors associated with nephrectomy in patients with metastatic renal cell carcinoma. J. Urol. 181, 1013\u20131018 (2009). discussion 1018\u20131019.","journal-title":"J. Urol."},{"key":"70709_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.urology.2006.02.036","volume":"68","author":"RT Tripathi","year":"2006","unstructured":"Tripathi, R. T., Heilbrun, L. K., Jain, V. & Vaishampayan, U. N. Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma. Urology 68, 296\u2013301 (2006).","journal-title":"Urology"},{"key":"70709_CR19","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1464-410X.2008.08119.x","volume":"103","author":"L Zini","year":"2009","unstructured":"Zini, L. et al. Race affects access to nephrectomy but not survival in renal cell carcinoma. BJU Int. 103, 889\u2013893 (2009).","journal-title":"BJU Int."},{"key":"70709_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1590\/S1677-55382011000100004","volume":"37","author":"A Sankin","year":"2011","unstructured":"Sankin, A., Cohen, J., Wang, H., Macchia, R. J. & Karanikolas, N. Rate of renal cell carcinoma subtypes in different races. Int. Braz. J. Urol. 37, 29\u201332 (2011). discussion 33-24.","journal-title":"Int. Braz. J. Urol."},{"key":"70709_CR21","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/j.1464-410X.2008.08259.x","volume":"103","author":"U Capitanio","year":"2009","unstructured":"Capitanio, U. et al. A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study. BJU Int. 103, 1496\u20131500 (2009).","journal-title":"BJU Int."},{"key":"70709_CR22","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.juro.2009.12.035","volume":"183","author":"BC Leibovich","year":"2010","unstructured":"Leibovich, B. C. et al. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma. J. Urol. 183, 1309\u20131315 (2010).","journal-title":"J. Urol."},{"key":"70709_CR23","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","volume":"27","author":"JC Cheville","year":"2003","unstructured":"Cheville, J. C., Lohse, C. M., Zincke, H., Weaver, A. L. & Blute, M. L. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am. J. Surg. Pathol. 27, 612\u2013624 (2003).","journal-title":"Am. J. Surg. Pathol."},{"key":"70709_CR24","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm.3029","volume":"19","author":"S Vanharanta","year":"2013","unstructured":"Vanharanta, S. et al. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat. Med. 19, 50\u201356 (2013).","journal-title":"Nat. Med."},{"key":"70709_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clgc.2018.10.002","volume":"17","author":"AM Saad","year":"2019","unstructured":"Saad, A. M. et al. Trends in renal-cell carcinoma incidence and mortality in the United States in the last 2 decades: a SEER-based study. Clin. Genitourin. Cancer 17, 46\u201357.e45 (2019).","journal-title":"Clin. Genitourin. Cancer"},{"key":"70709_CR26","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1056\/NEJMra1601333","volume":"376","author":"TK Choueiri","year":"2017","unstructured":"Choueiri, T. K. & Motzer, R. J. Systemic therapy for metastatic renal-cell carcinoma. N. Engl. J. Med. 376, 354\u2013366 (2017).","journal-title":"N. Engl. J. Med."},{"key":"70709_CR27","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1470-2045(16)30125-5","volume":"17","author":"D Cella","year":"2016","unstructured":"Cella, D. et al. Quality of life in patients with advanced renal cell carcinoma given nivolumab versus everolimus in CheckMate 025: a randomised, open-label, phase 3 trial. Lancet Oncol. 17, 994\u20131003 (2016).","journal-title":"Lancet Oncol."},{"key":"70709_CR28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/cam4.574","volume":"5","author":"P Li","year":"2016","unstructured":"Li, P. et al. Survival among patients with advanced renal cell carcinoma in the pretargeted versus targeted therapy eras. Cancer Med. 5, 169\u2013181 (2016).","journal-title":"Cancer Med."},{"key":"70709_CR29","doi-asserted-by":"publisher","first-page":"2388","DOI":"10.1056\/NEJMsa053935","volume":"356","author":"ES Ford","year":"2007","unstructured":"Ford, E. S. et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N. Engl. J. Med 356, 2388\u20132398 (2007).","journal-title":"N. Engl. J. Med"},{"key":"70709_CR30","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/CIRCRESAHA.116.309115","volume":"120","author":"GA Mensah","year":"2017","unstructured":"Mensah, G. A. et al. Decline in cardiovascular mortality: possible causes and implications. Circ. Res. 120, 366\u2013380 (2017).","journal-title":"Circ. Res."},{"key":"70709_CR31","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1093\/eurheartj\/ehz766","volume":"40","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon, K. M. et al. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 40, 3889\u20133897 (2019).","journal-title":"Eur. Heart J."},{"key":"70709_CR32","doi-asserted-by":"publisher","first-page":"938.e939","DOI":"10.1016\/j.urolonc.2020.08.034","volume":"38","author":"H Anastos","year":"2020","unstructured":"Anastos, H. et al. Black race may be associated with worse overall survival in renal cell carcinoma patients. Urol. Oncol. 38, 938.e939\u2013938.e917 (2020).","journal-title":"Urol. Oncol."},{"key":"70709_CR33","doi-asserted-by":"crossref","unstructured":"Sims, J. N. et al. Racial disparities and preventive measures to renal cell carcinoma. Int. J. Environ. Res. Public Health 15, 1089 (2018).","DOI":"10.3390\/ijerph15061089"},{"key":"70709_CR34","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1016\/j.clgc.2018.10.012","volume":"17","author":"K Batai","year":"2019","unstructured":"Batai, K. et al. Racial and ethnic disparities in renal cell carcinoma: an analysis of clinical characteristics. Clin. Genitourin. Cancer 17, e195\u2013e202 (2019).","journal-title":"Clin. Genitourin. Cancer"},{"key":"70709_CR35","doi-asserted-by":"publisher","first-page":"2975","DOI":"10.1001\/jama.283.22.2975","volume":"283","author":"HG Welch","year":"2000","unstructured":"Welch, H. G., Schwartz, L. M. & Woloshin, S. Are increasing 5-year survival rates evidence of success against cancer?. JAMA 283, 2975\u20132978 (2000).","journal-title":"JAMA"},{"key":"70709_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jamasurg.2020.6257","volume":"156","author":"MJ Best","year":"2021","unstructured":"Best, M. J., McFarland, E. G., Thakkar, S. C. & Srikumaran, U. Racial disparities in the use of surgical procedures in the US. JAMA Surg. 156, 274\u2013281 (2021).","journal-title":"JAMA Surg."},{"key":"70709_CR37","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s11606-013-2441-1","volume":"28","author":"EN Chapman","year":"2013","unstructured":"Chapman, E. N., Kaatz, A. & Carnes, M. Physicians and implicit bias: How doctors may unwittingly perpetuate health care disparities. J. Gen. Intern. Med. 28, 1504\u20131510 (2013).","journal-title":"J. Gen. Intern. Med."},{"key":"70709_CR38","first-page":"56","volume":"14","author":"BR Kennedy","year":"2007","unstructured":"Kennedy, B. R., Mathis, C. C. & Woods, A. K. African Americans and their distrust of the health care system: healthcare for diverse populations. J. Cult. Divers. 14, 56\u201360 (2007).","journal-title":"J. Cult. Divers."},{"key":"70709_CR39","doi-asserted-by":"publisher","first-page":"e183146","DOI":"10.1001\/jamanetworkopen.2018.3146","volume":"1","author":"JM O\u2019Connor","year":"2018","unstructured":"O\u2019Connor, J. M., Sedghi, T., Dhodapkar, M., Kane, M. J. & Gross, C. P. Factors associated with cancer disparities among low-, medium-, and high-income US counties. JAMA Netw. Open 1, e183146 (2018).","journal-title":"JAMA Netw. Open"},{"key":"70709_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.urology.2021.08.070","volume":"165","author":"MR Metcalf","year":"2022","unstructured":"Metcalf, M. R. et al. Disparities in the treatment and survival of metastatic renal cell carcinoma. Urology 165, 89\u201397 (2022).","journal-title":"Urology"},{"key":"70709_CR41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s10552-015-0594-4","volume":"26","author":"J Lin","year":"2015","unstructured":"Lin, J. et al. Survival among Black and White patients with renal cell carcinoma in an equal-access health care system. Cancer Causes Control 26, 1019\u20131026 (2015).","journal-title":"Cancer Causes Control"},{"issue":"Suppl","key":"70709_CR42","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1177\/0022146510383498","volume":"51","author":"JC Phelan","year":"2010","unstructured":"Phelan, J. C., Link, B. G. & Tehranifar, P. Social conditions as fundamental causes of health inequalities: theory, evidence, and policy implications. J. Health Soc. Behav. 51(Suppl), S28\u2013S40 (2010).","journal-title":"J. Health Soc. Behav."},{"key":"70709_CR43","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/ije\/30.4.668","volume":"30","author":"N Krieger","year":"2001","unstructured":"Krieger, N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int. J. Epidemiol. 30, 668\u2013677 (2001).","journal-title":"Int. J. Epidemiol."},{"key":"70709_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.15585\/mmwr.mm7014e1","volume":"70","author":"FB Ahmad","year":"2021","unstructured":"Ahmad, F. B., Cisewski, J. A., Mini\u00f1o, A. & Anderson, R. N. Provisional mortality data\u2014United States, 2020. MMWR Morb. Mortal. Wkly. Rep. 70, 519\u2013522 (2021).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"70709_CR45","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.15585\/mmwr.mm7033a2","volume":"70","author":"LM Rossen","year":"2021","unstructured":"Rossen, L. M. et al. Disparities in excess mortality associated with COVID-19\u2014United States, 2020. MMWR Morb. Mortal. Wkly. Rep. 70, 1114\u20131119 (2021).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"70709_CR46","doi-asserted-by":"publisher","first-page":"e227067","DOI":"10.1001\/jamanetworkopen.2022.7067","volume":"5","author":"SH Woolf","year":"2022","unstructured":"Woolf, S. H., Masters, R. K. & Aron, L. Y. Changes in life expectancy between 2019 and 2020 in the US and 21 peer countries. JAMA Netw. Open 5, e227067 (2022).","journal-title":"JAMA Netw. Open"},{"key":"70709_CR47","doi-asserted-by":"publisher","first-page":"100688","DOI":"10.1016\/j.eclinm.2020.100688","volume":"31","author":"Q Wang","year":"2021","unstructured":"Wang, Q., Davis, P. B. & Xu, R. COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States. EClinicalMedicine 31, 100688 (2021).","journal-title":"EClinicalMedicine"},{"key":"70709_CR48","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","volume":"395","author":"NM Kuderer","year":"2020","unstructured":"Kuderer, N. M. et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395, 1907\u20131918 (2020).","journal-title":"Lancet"},{"key":"70709_CR49","doi-asserted-by":"publisher","first-page":"e2411656","DOI":"10.1001\/jamanetworkopen.2024.11656","volume":"7","author":"JRC Sumibcay","year":"2024","unstructured":"Sumibcay, J. R. C., Kunichoff, D. & Bassett, M. T. Racial and ethnic disparities in COVID-19 mortality. JAMA Netw. Open 7, e2411656\u2013e2411656 (2024).","journal-title":"JAMA Netw. Open"},{"key":"70709_CR50","doi-asserted-by":"publisher","first-page":"242","DOI":"10.2105\/AJPH.71.3.242","volume":"71","author":"C Percy","year":"1981","unstructured":"Percy, C., Stanek, E. 3rd & Gloeckler, L. Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am. J. Public Health 71, 242\u2013250 (1981).","journal-title":"Am. J. Public Health"},{"key":"70709_CR51","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/postgradmedj-2012-130912","volume":"88","author":"TJ Cheng","year":"2012","unstructured":"Cheng, T. J., Lin, C. Y., Lu, T. H. & Kawachi, I. Reporting of incorrect cause-of-death causal sequence on death certificates in the USA: using hypertension and diabetes as an educational illustration. Postgrad. Med. J. 88, 690\u2013693 (2012).","journal-title":"Postgrad. Med. J."},{"key":"70709_CR52","doi-asserted-by":"publisher","first-page":"e158","DOI":"10.1016\/S2589-7500(20)30314-9","volume":"3","author":"C Lee","year":"2021","unstructured":"Lee, C. et al. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database. Lancet Digit. Health 3, e158\u2013e165 (2021).","journal-title":"Lancet Digit. Health"},{"key":"70709_CR53","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jclinepi.2012.09.017","volume":"66","author":"A Latouche","year":"2013","unstructured":"Latouche, A., Allignol, A., Beyersmann, J., Labopin, M. & Fine, J. P. A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J. Clin. Epidemiol. 66, 648\u2013653 (2013).","journal-title":"J. Clin. Epidemiol."},{"key":"70709_CR54","unstructured":"Therneau, T., Crowson, C. & Atkinson, E. Using Time Dependent Covariates and Time Dependent Coefficients in the Cox Model. The Comprehensive R Archive Network https:\/\/cran.r-project.org\/web\/packages\/survival\/vignettes\/timedep.pdf (2023)."},{"key":"70709_CR55","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jclinepi.2021.08.001","volume":"142","author":"JC Digitale","year":"2022","unstructured":"Digitale, J. C., Martin, J. N. & Glymour, M. M. Tutorial on directed acyclic graphs. J. Clin. Epidemiol. 142, 264\u2013267 (2022).","journal-title":"J. Clin. Epidemiol."},{"key":"70709_CR56","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1200\/JCO.2017.74.2049","volume":"36","author":"L Ellis","year":"2018","unstructured":"Ellis, L. et al. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J. Clin. Oncol. 36, 25\u201333 (2018).","journal-title":"J. Clin. Oncol."},{"key":"70709_CR57","doi-asserted-by":"publisher","first-page":"e030248","DOI":"10.1136\/bmjopen-2019-030248","volume":"9","author":"XQ Yu","year":"2019","unstructured":"Yu, X. Q., Goldsbury, D., Yap, S., Yap, M. L. & O\u2019Connell, D. L. Contributions of prognostic factors to socioeconomic disparities in cancer survival: protocol for analysis of a cohort with linked data. BMJ Open 9, e030248 (2019).","journal-title":"BMJ Open"},{"key":"70709_CR58","doi-asserted-by":"publisher","unstructured":"Yingwei, X., Yishan, Z., Shuang, L. & Hao, P. Racial and ethnic disparities in the cause of death for clear cell renal cell carcinoma. Zenodo, https:\/\/doi.org\/10.5281\/zenodo.17510506 (2025).","DOI":"10.5281\/zenodo.17510506"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70709-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70709-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70709-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:29:15Z","timestamp":1785518955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-70709-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,28]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["70709"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-70709-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,28]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7553"}}